{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:06:31Z","timestamp":1795017991418,"version":"4.10.1"},"reference-count":50,"publisher":"Xia & He Publishing","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["gene expr"],"published-print":{"date-parts":[[2014,4,16]]},"abstract":"<jats:p>Hepatocellular carcinoma is an emerging worldwide health threat that has few curative treatment options and poor overall survival. Progressive hepatic fibrosis is a common pathway for all forms of chronic liver disease and is closely linked epidemiologically to hepatocellular carcinoma\n risk. However, the molecular events that predispose a fibrotic liver to cancer development remain elusive. Nonetheless, a permissive hepatic microenvironment provides fertile soil for transition of damaged hepatocytes into hepatocellular carcinoma. Key predisposing features include alterations\n in the extracellular matrix, bidirectional signaling pathways between parenchymal and nonparenchymal cells, and immune dysfunction. Emerging research into the contributions of autophagy, tumor-associated fibroblasts, and hepatocellular carcinoma progenitor cells to this dangerous milieu also\n provides new mechanistic underpinnings to explain the contribution of fibrosis to cancer. As effective antifibrotic therapies are developed, these approaches could attenuate the rising surge of hepatocellular carcinoma associated with chronic liver disease.<\/jats:p>","DOI":"10.3727\/105221614x13919976902057","type":"journal-article","created":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T19:48:16Z","timestamp":1397677696000},"page":"77-84","source":"Crossref","is-referenced-by-count":59,"title":["Hepatic Fibrosis and the Microenvironment: Fertile Soil for Hepatocellular Carcinoma Development"],"prefix":"10.14218","volume":"16","author":[{"given":"Michael C.","family":"Wallace","sequence":"first","affiliation":[{"name":"Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","reference":[{"key":"b1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","year":"2008","journal-title":"J Pathol"},{"key":"b2","doi-asserted-by":"crossref","first-page":"C216","DOI":"10.1152\/ajpcell.00328.2012","article-title":"Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis","volume":"304","year":"2013","journal-title":"Am J Physiol Cell Physiol"},{"key":"b3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"b4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"b5","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review","volume":"10","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"b6","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","year":"2012","journal-title":"Lancet"},{"key":"b7","first-page":"213","article-title":"Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis","volume":"9","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"b8","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.bbadis.2012.10.013","article-title":"Fibroblasts as architects of cancer pathogenesis","volume":"1832","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"b9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ccm.2011.12.005","article-title":"Idiopathic pulmonary fibrosis: Phenotypes and comorbidities","volume":"33","year":"2012","journal-title":"Clin Chest Med"},{"key":"b10","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3892\/ijo.2013.1829","article-title":"Human hepatocyte carcinogenesis (review)","volume":"42","year":"2013","journal-title":"Int J Oncol"},{"key":"b11","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.gastro.2013.01.002","article-title":"Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma","volume":"144","year":"2013","journal-title":"Gastroenterology"},{"key":"b12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver","volume":"88","year":"2008","journal-title":"Physiol Rev"},{"key":"b13","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.2174\/092986712803341520","article-title":"Role of oxidative stress and molecular changes in liver fibrosis: A review","volume":"19","year":"2012","journal-title":"Curr Med Chem"},{"key":"b14","first-page":"349","article-title":"Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress","volume":"387","year":"2006","journal-title":"Biol Chem"},{"key":"b15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1751-2980.2011.00569.x","article-title":"Oxidative stress and redox signaling mechanisms of alcoholic liver disease: Updated experimental and clinical evidence","volume":"13","year":"2012","journal-title":"J Dig Dis"},{"key":"b16","article-title":"Role of NADPH oxidases in liver fibrosis","journal-title":"Antioxid Redox Signal"},{"key":"b17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3390\/v5020439","article-title":"HCV and oxidative stress in the liver","volume":"5","year":"2013","journal-title":"Viruses"},{"key":"b18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3449","article-title":"Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma","volume":"13","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"b19","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: A tale of two \u201chits\u201d?","volume":"114","year":"1998","journal-title":"Gastroenterology"},{"key":"b20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2011.10.003","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis","volume":"52","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"b21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-kappaB in the liver\u2014Linking injury, fibrosis and hepatocellular carcinoma","volume":"8","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"b22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ccr.2006.12.016","article-title":"Deletion of NEMO\/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma","volume":"11","year":"2007","journal-title":"Cancer Cell"},{"key":"b23","first-page":"143","article-title":"Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease (review)","volume":"24","year":"2009","journal-title":"Int J Mol Med"},{"key":"b24","article-title":"Novel cancer-targeting agents\/application strategies developed from MMP Science","journal-title":"Anticancer Agents Med Chem"},{"key":"b25","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/jmv.23571","article-title":"Expression of matrix metalloproteinases and their inhibitors in the woodchuck model of hepatocellular carcinoma","volume":"85","year":"2013","journal-title":"J Med Virol"},{"issue":"12","key":"b26","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.cgh.2013.07.034","article-title":"Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: A systematic review and meta-analysis","volume":"11","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"b27","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/hep.24108","article-title":"Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells","volume":"53","year":"2011","journal-title":"Hepatology"},{"key":"b28","doi-asserted-by":"crossref","first-page":"30708","DOI":"10.1074\/jbc.M113.478685","article-title":"Transforming growth factor-beta (TGF-beta)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation","volume":"288","year":"2013","journal-title":"J Biol Chem"},{"key":"b29","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1073\/pnas.0409722102","article-title":"Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma","volume":"102","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"b30","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.28421","article-title":"Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: Evidence for stromal induction of hepatocellular carcinoma","volume":"134","year":"2014","journal-title":"Int J Cancer"},{"key":"b31","doi-asserted-by":"crossref","first-page":"G425","DOI":"10.1152\/ajpgi.00050.2011","article-title":"Role of integrins in fibrosing liver diseases","volume":"301","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"b32","first-page":"163","article-title":"Signalling via integrins: Implications for cell survival and anticancer strategies","volume":"1775","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"b33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1517\/14728222.2011.555402","article-title":"Targeting integrins in hepatocellular carcinoma","volume":"15","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"b34","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/hep.26115","article-title":"Natural killer cells in liver disease","volume":"57","year":"2013","journal-title":"Hepatology"},{"key":"b35","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/hep.22413","article-title":"Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis","volume":"48","year":"2008","journal-title":"Hepatology"},{"key":"b36","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.it.2003.09.007","article-title":"NK cells and the tumour microenvironment: Implications for NK-cell function and anti-tumour activity","volume":"24","year":"2003","journal-title":"Trends Immunol"},{"key":"b37","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/carcin\/bgr133","article-title":"Genomic modeling of tumor onset and progression in a mouse model of aggressive human liver cancer","volume":"32","year":"2011","journal-title":"Carcinogenesis"},{"key":"b38","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.yexcr.2010.02.045","article-title":"Hallmarks of cancer: Interactions with the tumor stroma","volume":"316","year":"2010","journal-title":"Exp Cell Res"},{"key":"b39","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4161\/auto.25063","article-title":"Functions of autophagy in normal and diseased liver","volume":"9","year":"2013","journal-title":"Autophagy"},{"key":"b40","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.gastro.2011.12.044","article-title":"Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues","volume":"142","year":"2012","journal-title":"Gastroenterology"},{"key":"b41","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1101\/gad.2016211","article-title":"Autophagy-deficient mice develop multiple liver tumors","volume":"25","year":"2011","journal-title":"Genes Dev"},{"key":"b42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.gastro.2012.04.009","article-title":"miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions","volume":"143","year":"2012","journal-title":"Gastroenterology"},{"key":"b43","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/j.seminoncol.2012.05.003","article-title":"Gene signatures in the management of hepatocellular carcinoma","volume":"39","year":"2012","journal-title":"Semin Oncol"},{"key":"b44","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa0804525","article-title":"Gene expression in fixed tissues and outcome in hepatocellular carcinoma","volume":"359","year":"2008","journal-title":"N Engl J Med"},{"key":"b45","doi-asserted-by":"crossref","first-page":"e1002147","DOI":"10.1371\/journal.pgen.1002147","article-title":"Extracellular matrix dynamics in hepatocarcinogenesis: A comparative proteomics study of PDGFC transgenic and Pten null mouse models","volume":"7","year":"2011","journal-title":"PLoS Genet"},{"issue":"7\u20138","key":"b46","first-page":"393","article-title":"Extracellular matrix transcriptome dynamics in hepatocellular carcinoma","volume":"32","year":"2013","journal-title":"Matrix Biol"},{"key":"b47","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cell.2013.09.031","article-title":"Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling","volume":"155","year":"2013","journal-title":"Cell"},{"key":"b48","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: Incidence and risk factors","volume":"127","year":"2004","journal-title":"Gastroenterology"},{"key":"b49","article-title":"EGFR inhibition attenuates liver fibrosis and development of hepatocellular carcinoma","journal-title":"Hepatology"},{"key":"b50","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","year":"2013","journal-title":"J Clin Invest"}],"container-title":["Gene Expression"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/cog\/ge\/2014\/00000016\/00000002\/art00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:15:58Z","timestamp":1783707358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.3727\/105221614X13919976902057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,16]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4,16]]}},"alternative-id":["1052-2166(20140416)16:2L.77;1-"],"URL":"https:\/\/doi.org\/10.3727\/105221614x13919976902057","relation":{},"ISSN":["1052-2166"],"issn-type":[{"value":"1052-2166","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4,16]]}}}